title: Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis.
abstract: OBJECTIVE
  We investigated the main biomolecular features in the evolution of aortic stenosis, focusing on advanced lesions.
  
  
  BACKGROUND
  "Degenerative" aortic valve stenosis shares risk factors and inflammatory similarities with atherosclerosis.
  
  
  METHODS
  We compared nonrheumatic stenotic aortic valves from 26 patients undergoing surgical valve replacement (group A) and 14 surgical control patients (group B). We performed semiquantitative histological and immunohistochemical analyses on valve leaflets to measure inflammation, sclerosis, calcium, neoangiogenesis, and intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression. We assessed heat shock protein 60 (hsp60) gene expression as an index of cellular stress and C-reactive protein, erythrocyte sedimentation rate, and fibrinogen as systemic inflammatory markers.
  
  
  RESULTS
  In group A valves, we found a prevalence of calcium nodules surrounded by activated inflammatory infiltrates, neovessels, and abundant ICAM-1, VCAM-1, and hsp60 gene expression. Specimens from group B were negative for all of these markers, except 2 of 14 positivity for hsp60. The presence of active inflammatory infiltrates correlated with an abundance of thin neovessels (p < 0.01) and hsp60 gene expression (p = 0.01), whereas neoangiogenesis correlated with inflammation (p = 0.04), calcium (p = 0.01), and hsp60 gene expression (p = 0.04).
  
  
  CONCLUSIONS
  "Degenerative" aortic valve stenosis appears to be a chronic inflammatory process associated with atherosclerotic risk factors. The coexistence of neoangiogenesis, T-lymphocyte infiltration, adhesion molecules, and hsp60 gene expression indicates an active immunomediated process in the final phases of the disease.
authors.affiliation: Department of Cardiology and Cardiac Surgery, CNR Institute of Clinical Physiology, Ospedale Pasquinucci, Massa, Italy. mazzone@ifc.cnr.it
authors.forename: Annamaria
authors.initials: A
authors.lastname: Mazzone
authors.forename: Maria Carmela
authors.initials: MC
authors.lastname: Epistolato
authors.forename: Raffaele
authors.initials: R
authors.lastname: De Caterina
authors.forename: Simona
authors.initials: S
authors.lastname: Storti
authors.forename: Simona
authors.initials: S
authors.lastname: Vittorini
authors.forename: Silverio
authors.initials: S
authors.lastname: Sbrana
authors.forename: Jacopo
authors.initials: J
authors.lastname: Gianetti
authors.forename: Stefano
authors.initials: S
authors.lastname: Bevilacqua
authors.forename: Mattia
authors.initials: M
authors.lastname: Glauber
authors.forename: Andrea
authors.initials: A
authors.lastname: Biagini
authors.forename: Piero
authors.initials: P
authors.lastname: Tanganelli
mesh_terms: D000368:Aged; D001024:Aortic Valve Stenosis / Q000235:genetics / Q000378:metabolism*; D015415:Biomarkers / Q000032:analysis; D002114:Calcinosis / Q000235:genetics / Q000378:metabolism*; D018834:Chaperonin 60 / Q000235:genetics / Q000378:metabolism*; D005260:Female; D005786:Gene Expression Regulation / Q000502:physiology; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D007150:Immunohistochemistry; D018836:Inflammation Mediators / Q000378:metabolism*; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D008055:Lipids / Q000097:blood; D008297:Male; D008859:Microscopy, Polarization; D008875:Middle Aged; D018919:Neovascularization, Physiologic / Q000502:physiology*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D013223:Statistics as Topic; D013601:T-Lymphocytes / Q000378:metabolism*; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism
chemical_list: D015415:Biomarkers; D018834:Chaperonin 60; D018836:Inflammation Mediators; D008055:Lipids; D012333:RNA, Messenger; D019010:Vascular Cell Adhesion Molecule-1; D018799:Intercellular Adhesion Molecule-1